PATENT CLAIM ANALYSIS

Application Number: 15965172
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "287000"]

Abstract:
The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by hepatitis B virus, and reducing the occurrence of serious conditions associated with HBV.

Claim (Index 2):
A compound according to  claim 1 , wherein the compound is of the formula: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15435137', '13126490', '14527328', '12582417', '15500870']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7947538675962509
- 35 USC 102 Novelty (BERT): 0.5842744195445567
- Combined Prediction Score: 0.7737059227910815
- Mean Citation Score: 402.550058
- Max Citation Score: 484.73166
- Similarity Product: 408.09841164992815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test